Medication Overview

Need new introductory text here…

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla vitae laoreet est. Duis interdum laoreet massa, at blandit libero cursus at. In est magna, porta quis massa vitae, tincidunt venenatis ligula. 

Action items for Medication Overview

Visit these 3 links for in-depth information and articles

Action item one

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla vitae laoreet est. Duis interdum laoreet massa, at blandit libero cursus at. In est magna, porta quis massa vitae, tincidunt venenatis ligula. 

Action item two

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla vitae laoreet est. Duis interdum laoreet massa, at blandit libero cursus at. In est magna, porta quis massa vitae, tincidunt venenatis ligula. 

Action item three

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla vitae laoreet est. Duis interdum laoreet massa, at blandit libero cursus at. In est magna, porta quis massa vitae, tincidunt venenatis ligula. 

FEATURE

TBD - will add after article migration

ADDITIONAL READING

At the annual meeting of the American Society of Hematology (ASH) 2021, Dr. Mathew Davids from the Dana-Farber Cancer Institute in Boston interviews Dr. Bill Wierda from the MD Anderson Cancer Center in Houston. They discuss the benefits of combined finite therapy to achieve U-MRD with a